Portfolio

Life Science
Therapeutics
Tools
Diagnostics/Medical Devices

Breakthrough Technology
BioEnergy/CleanTech
Nanotechnology
     BIND Biosciences
     Selecta Biosciences
     Seventh Sense Bio
     T2 Biosystems
Technology Platforms

 


All Companies by Name

Liquidity Events



Developing the first generation of nanoparticle immunomodulatory drugs Private 2008
Developing therapeutic targeted nanoparticles Private 2007
Developing on-body health awareness products Private 2007
Developing transformative in vitro and in vivo diagnostic products Private 2006





© 2009 Flagship Ventures. All rights reserved.